Cytostatics and immuno-suppressive drugs

Goorin, 1990, Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer, J. Pediatr., 1, 144, 10.1016/S0022-3476(05)81668-3 Hickey, 1989, Perioperative cardiovascular collapse in a patient previously treated with doxorubicin, Anesth. Analg., 69, 138, 10.1213/00000539-198907000-00031 Concetta Petti, 1989, Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA, Semin. Oncol., 16, 10 Janmohammed, 1989, Mitoxantrone induced congestive heart failure in patients previously treated with anthracyclines, Br. J. Haematol., 72, 292, 10.1111/j.1365-2141.1989.tb04270.x Kwok-Hung, 1989, Phase 2 study of mitoxantrone in unresectable primary hepatocellular carcinoma following hepatitis B infection, Cancer Chemother. Pharmacol., 23, 54 Sivanesaratnam, 1989, Mitomycin C cardiotoxicity, Med. J. Aust., 151, 300, 10.5694/j.1326-5377.1989.tb101205.x Navarro, 1989, Mitomycin C and vinblastine in advanced breast cancer, Oncology, 46, 137, 10.1159/000226702 Greipp, 1989, Phase 2 trial of amsacrine in patients with multiple myeloma, Med. Pediatr. Oncol., 17, 76, 10.1002/mpo.2950170116 Coninx, 1988, Sequential trial of initial chemotherapy for advanced cancer of the head and neck: DDP versus DDP+5-fluorouracil, Cancer, 62, 1888, 10.1002/1097-0142(19881101)62:9<1888::AID-CNCR2820620903>3.0.CO;2-M Murin, 1989, Development of myocardial infarction in a patient treated with 5-fluorouracil, Vnitrni Lekarstvi, 35, 1020 Mazoyer, 1989, Cardiotoxicity of 5-fluorouracil. A case report, Rev. Mal. Respir., 6, 551 Sasaki, 1989, A case of acute myocardial infarction after treatment with cisplatin, Jpn. J. Cancer Chemother., 16, 2289 Viens, 1988, Brain metastases of lung cacer: excessive toxicity of high dose VP-16-213, Eur. J. Cancer Clin. Oncol., 24, 1905, 10.1016/0277-5379(88)90107-1 Terpstra, 1989, Pericardial fibrosis following busulfan treatment, Neth. J. Med., 35, 249 Walsh, 1988, Cyclosporine and adult respiratory distress syndrome, Transplantation, 46, 776, 10.1097/00007890-198811000-00030 Schleusner, 1989, Busulfan lung, Z. Klin. Med., 44, 1595 Lagler, 1989, Akute Dyspnoe nach intravenöser Gabe von Vinblastin/Mitomycin C, Schweiz. Med. Wochenschr., 119, 290 Fehlauer, 1989, Methotrexate therapy in rheumatoid arthritis: 2 year retrospective follow up study, J. Rheumatol., 16, 307 Giles, 1990, Chlorambucil lung toxicity, Acta Haematol., 83, 156, 10.1159/000205195 Carella, 1988, High dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report, J. Clin. Oncol., 6, 1411, 10.1200/JCO.1988.6.9.1411 Heran, 1990, Cortical blindness during chemotherapy: clinical, CT and MR correlation, J. Comput. Assist. Tomogr., 14, 262, 10.1097/00004728-199003000-00019 Cattaneo, 1988, Transient blindness and seizure associated with cisplatin therapy, J. Cancer Res. Clin. Oncol., 114, 528, 10.1007/BF00391507 Newton, 1989, Intra-arterial cisplatin for the treatment of malignant gliomas, J. Neuro-Oncol., 7, 39, 10.1007/BF00149377 Follezou, 1989, Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase 2 study, Neoplasma, 36, 349 Urba, 1988, Retrobulbar neuritis in a patient treated with intraarterial cisplatin for head and neck cancer, Cancer, 62, 2094, 10.1002/1097-0142(19881115)62:10<2094::AID-CNCR2820621004>3.0.CO;2-Q Curran, 1989, Ocular adverse reactions associated with adriamycin (doxorubicin), Am. J. Ophthalmol., 108, 709, 10.1016/0002-9394(89)90866-0 Curran, 1989, Accidental acute exposure to doxorubicin, Cancer Nurs., 12, 329, 10.1097/00002820-198912000-00003 Elsa, 1989, Ocular complications after intracarotid BCNU for intracranial tumors, Acta Ophthalmol., 67, 83, 10.1111/j.1755-3768.1989.tb00728.x Rubin, 1989, Transient cortical blindness and occipital seizures with cyclosporine toxicity, Transplantation, 47, 572, 10.1097/00007890-198903000-00037 Wilson, 1988, Cyclosporin A induced reversible cortical blindness, J. Clin. Neuro-Ophthalmol., 8, 215 Kadoya, 1989, Two cases of anemic retinopathy, Folia Ophthalmol. Jpn., 40, 148 Shibutani, 1989, Methotrexate related multifocal axonopathy. Report of an autopsy case, Acta neuropathol., 79, 333, 10.1007/BF00294671 Hughes, 1989, Acute cerebral oedema induced by methotrexate, Br. Med. J., 298, 1315, 10.1136/bmj.298.6683.1315 Asada, 1988, Disseminated necrotizing encephalopathy induced by methotrexate therapy alone, Acta Pathol. Jpn., 38, 1305 Wernick, 1989, Central nervous system toxicity associated with weekly low dose methotrexate treatment, Arthritis Rheum., 32, 770, 10.1002/anr.1780320616 Ebner, 1989, MR findings in methotrexate induced CNS abnormalities, Am. J. Neuroradiol., 10, 959 Malapert, 1989, Painful legs and moving toes. Neuropathy due to cytosine arabinoside(ara C), Rev. Neurol., 145, 869 Saleh, 1989, Intrathecal cytosine arabinoside induced acute rapidly reversible paralysis, Am. J. Med., 86, 729, 10.1016/0002-9343(89)90459-2 Boesen, 1988, Severe persistent cerebellar dysfunction complicating cytosine arabinoside therapy, Acta Med. Scand., 224, 189, 10.1111/j.0954-6820.1988.tb16760.x Nevill, 1989, Horner's syndrome and demyelinating peripheral neuropathy caused by high dose cytosine arabinoside, Am. J. Hematol., 32, 314, 10.1002/ajh.2830320414 Pinkerton, 1989, A phase 2 study of ifosfamide in paediatric solid tumours, Cancer Chemother. Pharmacol., 24, S13, 10.1007/BF00253231 Lind, 1989, Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinoma, Cancer Res., 49, 735 Cooper, 1989, Does central nervous system toxicity occur in transplant patients with hypocholesterolemia receiving cyclosporine, J. Heart Transplant., 8, 221 Lind, 1989, Cyclosporin associated demyelination following allogeneic bone marrow transplantation, Hematol. Oncol., 7, 49, 10.1002/hon.2900070105 Kahn, 1989, Brachial plexopathy as a complication of intraarterial cisplatin chemotherapy, Cardiovasc. Intervent. Radiol., 12, 47, 10.1007/BF02577128 Vandenberg, 1988, Chlorambucil overdose: accidental ingestion of an antineoplastic drug, J. Emerg. Med., 6, 495, 10.1016/0736-4679(88)90407-6 McGuire, 1989, Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type 1, Med. Pediatr. Oncol., 17, 520, 10.1002/mpo.2950170534 Hall, 1989, Warning against use of intrathercal mitoxantrone, Lancet, April, 1, 734, 10.1016/S0140-6736(89)92256-3 Donegan, 1989, An unusual reaction to etoposide, DICP Ann. Pharmacother., 23, 177 Moore, 1990, Case report 5-fluorouracil neurotoxicity, Gynecol. Oncol., 36, 152, 10.1016/0090-8258(90)90127-7 Koeppler, 1989, High dose chemotherapy with autologous bone marrow surport in advanced malignant melanoma, Onkologie, 12, 277, 10.1159/000216662 Reed, 1989, Carboplatin and renal dysfunction, Ann. Intern. Med., 110, 409, 10.7326/0003-4819-110-5-409_1 Haupt, 1989, Very high dose cis-platinum (450 mg/sq m) in an infant with rhabdomyosarcoma, Anticancer Res., 9, 427 Noda, 1988, Phase 2 study of carboplatin for cervical carcinoma, Jpn. J. Cancer Chemother., 15, 3067 Sweeney, 1989, Hyperzincuria and hypozincemia in patients treated with cisplatin, Cancer, 63, 2093, 10.1002/1097-0142(19890601)63:11<2093::AID-CNCR2820631104>3.0.CO;2-N Heney, 1989, Acute ifosfamide induced tubular toxicity, Lancet, 8, 103, 10.1016/S0140-6736(89)90341-3 Newbury-Ecob, 1989, Ifosfamide induced Fanconi syndrome, Lancet, 10, 1328, 10.1016/S0140-6736(89)92719-0 Skinner, 1989, Hypophosphataemic rickets after ifosfamide treatment in children, Br. Med. J., 298, 1560, 10.1136/bmj.298.6687.1560 Skinner, 1989, Nephrotoxicity of ifosfamide in children, Lancet, 15, 159, 10.1016/S0140-6736(89)90213-4 Husband, 1988, Patal hypokalaemia associated with ifosfamide/mesna chemotherapy, Lancet, 14, 1116, 10.1016/S0140-6736(88)91942-3 Kraker, 1989, Experience with ifosfamide in paediatric tumours, Cancer Chemother. Pharmacol., 24, S28, 10.1007/BF00253235 Miyairi, 1989, A case of a syndrome of inappropriate secretion of antidiuretic hormone induced by cyclophosphamide therapy, Onkologie, 29, 179 Towler, 1989, Low dose cyclosporin a therapy in chronic posterior uveitis, Eye, 3, 282, 10.1038/eye.1989.39 Thigpen, 1988, Hexamethylmelamine as first line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase 2 trial of the gynecologic oncology group, Gynecol. Oncol., 31, 435, 10.1016/S0090-8258(88)80028-3 Davies, 1988, Amino-glutethimide induced hyperkalaemia, Br. J. Clin. Pharmacol., 43, 263 Vande-Walle, 1990, Association of fever, nasal congestion and rise in serum creatinine with azathioprine therapy, Pediatr. Nephrol., 4, 67, 10.1007/BF00858445 Mitchell, 1988, Syndrome of idiopathic hyperammonemia after high dose chemotherapy: review of nine cases, Am. J. Med., 85, 662, 10.1016/S0002-9343(88)80239-0 Ramalho, 1989, Hepatotoxicity of azathioprine in renal transplant recipients, Transplant. Proc., 21, 1716 Fonseca, 1988, Portal hypertension secondary to azathioprine in myasthenia gravis, Postgrad. Med. J., 64, 950, 10.1136/pgmj.64.758.950 Small, 1989, Probable azathioprine hepatotoxicity: a case report, Ann. Allergy, 62, 518 Hilton, 1989, Daily profiles of plasma phenylalanine and tyrosine in patients with osteogenic sarcoma during treatment with high dose methotrexate citrovorum rescue, Med. Pediatr. Oncol., 17, 265, 10.1002/mpo.2950170404 Shergy, 1988, Methotrexate associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis, Am. J. Med., 85, 771, 10.1016/S0002-9343(88)80019-6 Paschke, 1988, Hepatotoxizität der Etoposid-Ifosfamid Kombination-Chemotherapy, Onkologie, 11, 273, 10.1159/000216556 Pritchard, 1989, Hepatotoxicity of actinomycin-D, Lancet, 21, 168, 10.1016/S0140-6736(89)91192-6 White, 1989, Actinomycin-D induced hepatotoxicity, Pediatr. Hematol. Oncol., 6, 53, 10.3109/08880018909014582 Sack, 1989, Occlusion of biliary stents in hepatic transplantation caused by cyclosporine deposition, Transplantation, 47, 1068, 10.1097/00007890-198906000-00030 Ollenschlager, 1988, Asparaginase induced derangements of glutamine metabolism, the pathogenic basis of some drug related side effects, Eur. J. Clin. Invest., 18, 512, 10.1111/j.1365-2362.1988.tb01049.x Adang, 1989, Busulfan induced hepatic injury, Ned. Tijdschr. Geneeskd., 133, 1515 Ruiz, 1989, The influence of chemotherapy on plasma coagulation and fibrinolytic systems in lung cancer patients, Cancer, 63, 643, 10.1002/1097-0142(19890215)63:4<643::AID-CNCR2820630407>3.0.CO;2-J Lesesne, 1989, Cancer associated hemolytic uremic syndrome analysis of 85 cases from a national registry, J. Clin. Oncol., 7, 781, 10.1200/JCO.1989.7.6.781 Schick, 1989, M.R. diagnosis of dual venous sinus thrombosis complicating l-asparaginase therapy, Comput. Med. Imaging Graph., 13, 319, 10.1016/0895-6111(89)90209-7 Quismorio, 1988, Axillary vein thrombosis after nitrogen mustard therapy for S.L.E., J. Rheumatol., 15, 1732 Carter, 1988, Factor X deficiency during treatment of relapsed acute myeloid leukaemia with amsacrine, Clin. Lab. Haematol., 10, 225, 10.1111/j.1365-2257.1988.tb01176.x Walker, 1989, Carboplatin associated thrombotic microangiopathic hemolytic anemia, Cancer, 64, 1017, 10.1002/1097-0142(19890901)64:5<1017::AID-CNCR2820640508>3.0.CO;2-N Pollera, 1990, Dose and schedule effects of cisplatin on the related acute iron changes, Oncology, 47, 133, 10.1159/000226805 Kletter, 1988, Elevated serum iron levels following administration of cisplatinum, Oncology, 45, 421, 10.1159/000226657 Matsuyama, 1989, A variant of the chemotherapy associated erythrodysesthesia syndrome related to high dose cyclophosphamide, DICP Ann. Pharmacother., 23, 776 Jones JB, Puroy CY, Cyclophosphamide anaphylaxis. DICP Ann. Pharmacother., 23, 88. Green, 1989, Cutaneous vasculitis due to cyclophosphamide therapy for chronic lymphocytic leukemia, Aust. NZ J. Med., 19, 55, 10.1111/j.1445-5994.1989.tb01677.x Arrizabalaga, 1989, Dermatitis psoriasiforme masiva secundaria a instilacion intravesical de mitomycin C, Arch. Esp. Urol., 42, 670 Colver, 1990, Dermatitis due to intravesical mitomycin C: a delayed type hypersensitivity reaction?, Br. J. Dermatol., 122, 217, 10.1111/j.1365-2133.1990.tb08268.x Carstensen, 1989, Teniposide induced hypersensitivity reactions in children, Lancet, 1, 55, 10.1016/S0140-6736(89)90306-1 Nolte, 1988, VM-26, Am. J. Pediatr. Hematol./Oncol., 10, 308 Van de Kerkhof, 1988, Pyoderma gangrenosum in acute myloid leukaemia during immunosuppression, Eur. J. Pediatr., 148, 34, 10.1007/BF00441810 Siddall, 1989, Anaphylactic reactions to teniposide, Lancet, Febr., 18, 394, 10.1016/S0140-6736(89)91780-7 Salmeron, 1988, Lyell's syndrome in a patient with a cerebral multiform glioblastoma treated with procarbazine, Skin Cancer, 3, 261 Giguere, 1988, Procarbazine hypersensitivity manifested as a fixed drug eruption, Med. Pediatr. Oncol., 16, 378, 10.1002/mpo.2950160605 Jones, 1989, Anthracycline induced toxicity affecting palmar and plantar skin, Br. J. Cancer, 59, 814, 10.1038/bjc.1989.170 Cassidy, 1989, Hypersensitivity reaction to epirubicin, Med. Oncol. Tumor Pharmacother., 6, 297, 10.1007/BF02985165 Fondevila, 1989, Cutaneous vasculitis after intermediate dose of methotrexate (IDMTX), Br. J. Haematol., 72, 591, 10.1111/j.1365-2141.1989.tb04330.x Huber, 1990, Anaphylactoid-type reaction to methotrexate, Allergol. Jahrg., 13, S33 Williams, 1989, Hypersensitivity reaction to high dose cytarabine, Br. J. Haematol., 72, 274, 10.1111/j.1365-2141.1989.tb00267.x Korholz, 1990, Allergic reactions during treatment with l-asparaginase: role of specific IgE antibodies, Monatsschr. Kinderheilkd., 138, 23 Riedel, 1990, Gastrointestinal type 1 hypersensitivity to azathioprine, Klin. Wochenschr., 68, 50, 10.1007/BF01648893 Young, 1989, Graft versus host like reaction associated with 5-fluorouracil, Virgina Med., March, 125 Serrano, 1989, Decarbazine induced photosensitivity, Photodermatology, 6, 140 Horn, 1989, Observations and proposed mechanism of N,N′,N′-triethylenethiophosphoramide (thiotepa) induced hyperpigmentation, Arch. Dermatol., 125, 524, 10.1001/archderm.1989.01670160072011 de Groen, 1988, Cyclosporine, low density lipoprotein and cholesterol, Mayo Clin. Proc., 63, 1012, 10.1016/S0025-6196(12)64916-7 Raine, 1988, Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients, Nephrol. Dial. Transplant., 3, 458, 10.1093/oxfordjournals.ndt.a091698 Mejia, 1989, Cyclosporine associated diabetes mellitus in renal transplants, Clin. Transplant., 3, 260 Ballantyne, 1989, Effect of cyclosporine therapy on plasma lipoprotein levels, J. Am. Med. Assoc., 262, 53, 10.1001/jama.1989.03430010065032 Perrone, 1989, Endocrine function in subjects treated for childhood Hodgkin's disease, J. Pediatr. Endocrinol., 3, 175, 10.1515/JPEM.1989.3.3.175 Tokisue, 1988, Non-ketotic hyperosmolar diabetic coma induced by l-asparaginase in a diabetic patient with acute lymphoblastic leukemia and Down syndrome, J. Jpn. Diabet. Soc., 31, 863 Due, 1989, Thymic hyperplasia following chemotherapy of a testicular germ cell tumor, Cancer, 63, 446, 10.1002/1097-0142(19890201)63:3<446::AID-CNCR2820630309>3.0.CO;2-N Peters, 1989, High dose combination cyclophosphamide, cisplatin and mephalan with autologous bone marrow support, Cancer Chemother. Pharmacol., 23, 377, 10.1007/BF00435840 Feffer, 1989, Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate and 5-fluorouracil, Cancer, 63, 1303, 10.1002/1097-0142(19890401)63:7<1303::AID-CNCR2820630713>3.0.CO;2-F Borgeat, 1989, Leucémie aiguë monoblastique compliquée par une rupture splénique fatale après initiation de chimiothérapie, Schweiz. Med. Wochenstr., 119, 227 Werner, 1988, Paraplegia and quadriplegia after intrathecal chemotherapy, Arch. Phys. Med. Rehabil., 69, 1054 Shetty, 1988, White lines in the fingernails induced by combination chemotherapy, Br. Med. J., 297, 1635, 10.1136/bmj.297.6664.1635-a Shepherd, 1990, Idiopathic portal hypertension associated with cytotoxic drugs, J. Clin. Pathol., 43, 206, 10.1136/jcp.43.3.206 Domenech, 1988, Sudden hearing loss in an adolescent following a single dose of cisplatin, ORL, 50, 405, 10.1159/000276021 Embon, 1990, Nephrogenic adenoma in a patient with chronic renal failure associated with intravesical treatment with thiotepa, Eur. Urol., 17, 181, 10.1159/000464030 Dmochowski, 1990, Bladder contracture following intravesical doxorubicin therapy: case report and a review of the literature, J. Urol., 143, 816, 10.1016/S0022-5347(17)40106-6 Ricci, 1989, Spontaneous gastroduodenal perforation in cancer patients receiving cytotoxic therapy, J. Surg. Oncol., 41, 219, 10.1002/jso.2930410405 Hickish, 1989, Experience with intermediate-dose (110–120 mg/squ m) epirubicin, Cancer Chemother. Pharmacol., 24, 61, 10.1007/BF00254108 Vorobiof, 1989, Phase 2 study of high dose 4′-epidoxorubicin in the treatment of advanced gastrointestinal cancer, Eur. J. Cancer Clin. Oncol., 25, 563, 10.1016/0277-5379(89)90271-X Lifschitz, 1989, Low dose methotrexate induced changes in intestinal permeability determined by polyethylene glycol polymers, J. Pediatr. Gastroenterol. Nutr., 9, 301, 10.1097/00005176-198910000-00007 Goy, 1989, Myopathy as possible side effect of cyclosporin, Lancet, June, 24, 1446, 10.1016/S0140-6736(89)90147-5 Chassagne, 1989, Myopathy as possible side effect of cyclosporin, Lancet, Nov., 4, 1104, 10.1016/S0140-6736(89)91123-9 Fernandez-Sola, 1990, Reversible cyclosporin myopathy, Lancet, Feb., 10, 362, 10.1016/0140-6736(90)90658-R Grezard, 1989, Cyclosporin induced muscular toxicity, Lancet, 335, 177, 10.1016/0140-6736(90)90057-C Sciascia, 1989, Femoral osteonecrosis in patients with Hodgkin's disease treated with radio-chemotherapy, Radiol. Med., 77, 336 Reznik, 1989, Cyclosporine induces abnormal facial bone growth in children: a preliminary study, Pediatr. Nephrol., 3, 296, 10.1007/BF00858534 Meneghello, 1989, Aseptic osteonecrosis of the femoral head in cancer patients affected with vincristine/vinblastine induced neuropathy, Radiol. Med., 77, 626 Van Linthoudt, 1989, Does osteoporosis related to cytostatic drugs exist?, Med. Hypotheses, 29, 293, 10.1016/0306-9877(89)90114-X Blackburn, 1989, Impotence in three rheumatoid arthritis patients treated with methotrexate, Br. J. haematol., 73, 1341 Pujais, 1989, Osseous malformation in a baby born to woman on cyclosporin, Lancet, March, 25, 667 Meistrich, 1989, Recovery of sperm production after chemotherapy for osteosarcoma, Cancer, 63, 2115, 10.1002/1097-0142(19890601)63:11<2115::AID-CNCR2820631108>3.0.CO;2-A Schubert, 1989, Can the genetic risk be evaluated for offspring of testicular cancer patients exposed to chemotherapy treatment?, Aktuel. Urol., 20, 199, 10.1055/s-2008-1061213 Brown, 1988, The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas, Cancer Genet. Cytogenet., 36, 89, 10.1016/0165-4608(88)90078-7 Gris, 1989, Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with melphalan, Am. J. Hematol., 30, 47, 10.1002/ajh.2830300112 Bramswig, 1990, The effect of different cumulative doses of chemotherapy on testicular function, Cancer, 65, 1298, 10.1002/1097-0142(19900315)65:6<1298::AID-CNCR2820650607>3.0.CO;2-W Siimes, 1990, Small testicles with impaired production of sperm in adult male survivors of childhood malignancies, Cancer, 65, 1303, 10.1002/1097-0142(19900315)65:6<1303::AID-CNCR2820650608>3.0.CO;2-D Fernandez, 1989, Anhydramnios and cessation of fetal growth in a pregnant mother with polychemotherapy during the second trimester, Prenatal Diagn., 9, 681, 10.1002/pd.1970090913 Wallace, 1989, Gonadal dysfunction due to cis-platinum, Med. Pediatr. Oncol., 17, 409, 10.1002/mpo.2950170510 Leung, 1989, Fulminant hyperpyrexia induced by bleomycin, Postgrad. Med. J., 65, 417, 10.1136/pgmj.65.764.417 Akyol, 1990, Cytotoxic drug induced fever: a report on procarbazine induced hyperpyrexia, Med. Pediatr. Oncol., 18, 173, 10.1002/mpo.2950180217 Jeurissen, 1990, Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis, Ann. Rheum. Dis., 49, 25, 10.1136/ard.49.1.25 Fukutani, 1989, Effect of recombinant human granulocyte colony stimulating factor (RHG-CSF) in patients receiving chemotherapy phase 1 study, Jpn. J. Cancer Chemother., 16, 2005 Glaspy, 1989, Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony stimulating factor, Ann. Intern. Med., 109, 789, 10.7326/0003-4819-109-10-789 Ganser, 1989, Recombinant human granulocyte macrophage colony stimulating factor and low dose cytosine arabinoside in patients with myelodysplastic syndrome, Onkologie, 12, 13, 10.1159/000216589 Gluckman, 1989, Transient cyclic neutropenia following GM-CSF in a patient with chronic granulocytic leukemia transplanted with HLA-identical T cell depleted donor bone marrow, Bone Marrow Transplant., 4, 591 Spriggs, 1988, Recombinant human tumor necrosis factor administered as a 24 hour intravenous infusion. A phase 1 and pharmacologic study, J. Natl. Cancer Inst., 80, 1039, 10.1093/jnci/80.13.1039 Feinberg, 1988, A phase 1 trial of intravenously administered recombinant tumor necrosis factor alpha in cancer patients, J. Clin. Oncol., 6, 1328, 10.1200/JCO.1988.6.8.1328 Creaven, 1989, A phase 1 clinical trial of recombinant human tumor necrosis factor given daily for five days, Cancer Chemother. Pharmacol., 23, 186, 10.1007/BF00267953 Lenk, 1988, Human pharmacological investigation of a human recombinant tumor necrosis factor preparation (PAC-4D): a phase 1 trial, Arch. Geschwülstforsch., 58, S89 hegewisch, 1990, TNF induced cardiomyopathy, Lancet, 335, 294, 10.1016/0140-6736(90)90115-L Sosman, 1988, Repetitive weekly cycles of interleukin 2. Clinical and immunologic effects of dose, schedule, and addition of indomethacin, J. Natl. Cancer Inst., 80, 1451, 10.1093/jnci/80.18.1451 Richards, 1988, Phase 1 study of weekly 24 hour infusions of recombinant human interleukin 2, J. Natl. Cancer Inst., 80, 1325, 10.1093/jnci/80.16.1325 Nasr, 1989, A phase 1 study of interleukin 2 in children with cancer and evaluation of clinical and immunologic status during therapy, Cancer, 64, 783, 10.1002/1097-0142(19890815)64:4<783::AID-CNCR2820640402>3.0.CO;2-F Christiansen, 1988, Nephrotoxicity of continuous intravenous infusion of recombinant interleukin 2, Am. J. Med., 84, 1072, 10.1016/0002-9343(88)90314-2 Vander Molen, 1989, Adrenal insufficiency and interleukin 2 therapy, Ann. Intern. Med., 111, 185, 10.7326/0003-4819-111-2-185_1 Gast, 1989, Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha 2c in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients, Leukemia, 3, 453 Schultz, 1989, Induction of hyperthyroidism by interferon alpha 2b, Lancet, June, 24, 1452, 10.1016/S0140-6736(89)90157-8 Kinnula, 1989, Pharmacokinetics and toxicity of inhaled human interferon alpha in patients with lung cancer, J. Interferon Res., 9, 419, 10.1089/jir.1989.9.419 Schiller, 1988, Phase 2 trial of a recombination of interferon beta SER and interferon gamma in patients with advanced malignant melanoma, J. Interferon Res., 8, 581, 10.1089/jir.1988.8.581 Katz, 1988, Human leukocyte alpha interferon induced transient neurotoxicity in children, Invest. New Drugs, 6, 115, 10.1007/BF00195369 Adams, 1988, Interferon induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities, J. Neuro-Oncol., 6, 355, 10.1007/BF00177432